Risk Stratification and Its Complications in Diabetes
Module 1
Innovations in Personalized Diabetes Care and Risk Management
Early Identification of Metabolic Syndrome Risk
Improving Risk Stratification for Patients with Type 2 Myocardial Infarction
Comparisons of Polyexposure, Polygenic and Clinical Risk Scores in Risk Prediction of Type 2 Diabetes
Module 2
Clinical Utility of Cardiovascular Risk Scores for Identification of People with T2D More Likely to Benefit from Either GLP1 Receptor Agonists or SGLT2 Inhibitor Therapy
Association Between Team-Based Continuity of Care and Risk of Cardiovascular Diseases Among Patients with Diabetes
Association Between Team-Based Continuity of Care and Risk of Cardiovascular Diseases Among Patients with Diabetes
CRP, C-Peptide and Risk of First Time Cardiovascular Events and Mortality in Early T2D: A Danish Cohort Study
Module 3
Risk Assessment in Patients with Diabetes with the TIMI Risk Score for Atherothrombotic Disease
Associations of New-Onset Atrial Fibrillation with Risks of Cardiovascular Disease, Chronic Kidney Disease, and Mortality Among Patients with Type 2 Diabetes
Increased Risk of Severe Hypoglycemic Events Before and After Cardiovascular Outcomes in TECOS Suggests an At-Risk Type 2 Diabetes Frail Patient Phenotype
Association Between Specificity of Sulfonylureas to Cardiac Mitochondrial KATP Channels and the Risk of Major Adverse Cardiovascular Events in Type 2 Diabetes
Module 4
Advanced Glycation End Products Predict Loss of Renal Function and High-Risk Chronic Kidney Disease in Type 2 Diabetes
One Risk Assessment Tool for Cardiovascular Disease, Type 2 Diabetes, and chronic kidney disease
Innovations in personalised diabetes care and risk management
Risk stratification using Artificial Intelligence
Previous Lesson
Next Lesson
Early Identification of Metabolic Syndrome Risk
Risk Stratification and Its Complications in Diabetes
Early Identification of Metabolic Syndrome Risk
Previous Lesson
Back to Course
Next Lesson